Diagnostic discrimination of live attenuated influenza vaccine strains and community-acquired pathogenic strains in clinical samples

Molecular and Cellular Probes

Volumn 21, Issue 2, 2007, Pages 103-110

  Freed, Nikki E ^a   Myers, Christopher A ^a   Russell, Kevin L ^a   Walter, Elizabeth A ^b   Irvine, Marina ^a   Coon, Robert G ^a   Metzgar, David ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Lackland Air Force Base ^*  (United States)

Author keywords

FluMist; LAIV; PCR; RT PCR; Vaccine shedding

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS SHEDDING; VIRUS STRAIN;

BASE SEQUENCE; COMMUNITY-ACQUIRED INFECTIONS; DNA PRIMERS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES, ATTENUATED;

FIGWORT MOSAIC VIRUS;

EID: 33846083091     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2006.08.007     Document Type: Article

References (9)

1. Cha T.A., Kao K., Zhao J., Fast P.E., Mendelman P.M., and Arvin A. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol 38 (2000) 839-845
2. Maassab H.F., and Bryant M.L. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev Med Virol 9 (1999) 237-244
3. Jin H., Lu B., Zhou H., Ma C., Zhao J., Yang C.F., et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist™) derived from cold-adapted A/Ann Arbor/6/60. Virology 306 (2003) 18-24
4. Ali T., Scott N., Kallas W., Halliwell M.E., Savino C., Rosenberg E., et al. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist™). Clin Infect Dis 38 (2004) 760-762
5. Talbot T.R., Crocker D.D., Peters J., Doersam J.K., Ikizler M.R., Sannella E., et al. Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Infect Control Hosp Epidemiol 26 (2005) 494-500
6. Pregliasco F., Mensi C., Camorali L., and Anselmi G. Comparison of RT-PCR with other diagnostic assays for rapid detection of influenza viruses. J Med Virol 56 (1998) 168-173
7. Fouchier R.A.M., Bestebroer T.M., Herfst S., Van Der Kemp L., Rimmelzwaan G.F., and Osterhaus A.D.M.E. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol 38 (2000) 4096-4101
8. Ferguson N.M., Galvani A.P., and Bush R.M. . Ecological and immunological determinants of influenza evolution,. Nature 422 (2003) 428-433
9. Macken C., Lu H., Goodman J., and Boykin L. The value of a database in surveillance and vaccine selection. In: Osterhaus A.D.M.E., Cox N., and Hampson A.W. (Eds). Options for the control of influenza IV (2001), Elsevier Science, Amsterdam 103-106